Lv3
230 积分 2022-03-14 加入
Phthalazine PDE4 inhibitors. Part 3: the synthesis and in vitro evaluation of derivatives with a hydrogen bond acceptor
32分钟前
待确认
Product Class 18: Pyridopyridazines
49分钟前
已完结
Product Class 10: Phthalazines
54分钟前
已完结
ChemInform Abstract: Quinazolineacetic Acids and Related Analogues as Aldose Reductase Inhibitors
56分钟前
已完结
Concurrent alkylation‐methoxylation of 4,5‐dihalopyridazin‐6‐ones and synthesis of 5‐halo‐4‐hydroxypyridazin‐6‐ones
1小时前
已完结
Transition‐metal‐free cyclization of mucohalic acids with sulfonyl hydrazides: An approach to pyridazin‐3(2H)‐ones
1小时前
已完结
Loxo-305, a Highly Selective and Non-Covalent Next Generation BTK Inhibitor, Inhibits Diverse BTK C481 Substitution Mutations
8个月前
已完结
Pirtobrutinib: First Non-covalent Tyrosine Kinase Inhibitor for Treating Relapsed or Refractory Mantle Cell Lymphoma in Adults
8个月前
已完结
Pirtobrutinib: A New and Distinctive Treatment Option for B-Cell Malignancies
8个月前
已完结
FDA Approval Summary: Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma
8个月前
已完结
皖公网安备34019202002308
